X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs LUPIN LTD - Comparison Results

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE LUPIN LTD SUVEN LIFE/
LUPIN LTD
 
P/E (TTM) x 17.6 29.6 59.4% View Chart
P/BV x 3.8 2.8 135.7% View Chart
Dividend Yield % 0.6 0.6 101.3%  

Financials

 SUVEN LIFE   LUPIN LTD
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
LUPIN LTD
Mar-18
SUVEN LIFE/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs2511,465 17.1%   
Low Rs155727 21.3%   
Sales per share (Unadj.) Rs49.1349.6 14.1%  
Earnings per share (Unadj.) Rs9.75.6 174.8%  
Cash flow per share (Unadj.) Rs11.429.6 38.5%  
Dividends per share (Unadj.) Rs1.505.00 30.0%  
Dividend yield (eoy) %0.70.5 162.1%  
Book value per share (Unadj.) Rs60.3300.3 20.1%  
Shares outstanding (eoy) m127.28452.08 28.2%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x4.13.1 131.7%   
Avg P/E ratio x20.9197.2 10.6%  
P/CF ratio (eoy) x17.837.1 48.1%  
Price / Book Value ratio x3.43.6 92.2%  
Dividend payout %15.490.0 17.2%   
Avg Mkt Cap Rs m25,825495,502 5.2%   
No. of employees `0001.117.0 6.3%   
Total wages/salary Rs m61328,647 2.1%   
Avg. sales/employee Rs Th5,832.69,273.6 62.9%   
Avg. wages/employee Rs Th571.51,681.0 34.0%   
Avg. net profit/employee Rs Th1,153.8147.4 782.6%   
INCOME DATA
Net Sales Rs m6,253158,042 4.0%  
Other income Rs m2331,504 15.5%   
Total revenues Rs m6,485159,545 4.1%   
Gross profit Rs m1,98231,475 6.3%  
Depreciation Rs m21310,859 2.0%   
Interest Rs m462,044 2.3%   
Profit before tax Rs m1,95520,076 9.7%   
Minority Interest Rs m0-71 0.0%   
Prior Period Items Rs m035 0.0%   
Extraordinary Inc (Exp) Rs m0-14,644 0.0%   
Tax Rs m7182,885 24.9%   
Profit after tax Rs m1,2372,513 49.2%  
Gross profit margin %31.719.9 159.1%  
Effective tax rate %36.714.4 255.7%   
Net profit margin %19.81.6 1,244.2%  
BALANCE SHEET DATA
Current assets Rs m5,622122,095 4.6%   
Current liabilities Rs m1,16850,956 2.3%   
Net working cap to sales %71.245.0 158.3%  
Current ratio x4.82.4 201.0%  
Inventory Days Days8185 96.3%  
Debtors Days Days36120 30.0%  
Net fixed assets Rs m3,325129,876 2.6%   
Share capital Rs m127904 14.1%   
"Free" reserves Rs m7,547134,866 5.6%   
Net worth Rs m7,674135,771 5.7%   
Long term debt Rs m1464,245 0.0%   
Total assets Rs m9,135263,054 3.5%  
Interest coverage x43.210.8 399.3%   
Debt to equity ratio x00.5 0.4%  
Sales to assets ratio x0.70.6 113.9%   
Return on assets %14.01.7 811.0%  
Return on equity %16.11.9 870.9%  
Return on capital %26.03.7 699.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,06653,141 9.5%   
Fx outflow Rs m2,00119,335 10.4%   
Net fx Rs m3,06533,807 9.1%   
CASH FLOW
From Operations Rs m69917,512 4.0%  
From Investments Rs m-6-14,073 0.0%  
From Financial Activity Rs m-577-14,921 3.9%  
Net Cashflow Rs m116-11,482 -1.0%  

Share Holding

Indian Promoters % 63.4 46.6 136.1%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 0.0 31.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 10.1 361.4%  
Shareholders   37,287 98,259 37.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   PLETHICO PHARMA  BIOCON LTD  J.B.CHEMICALS  ALKEM LABORATORIES  DIVIS LABORATORIES  

Compare SUVEN LIFE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 331 Points Higher; Oil & Gas Stocks Witness Buying(Closing)

After opening on a negative note, share markets in India witnessed buying interest during closing hours and ended the day on a positive note.

Related Views on News

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

3 Big Money Makers to Round Out Your 2018 Portfolio(Profit Hunter)

Oct 31, 2018

The market is offering many strong opportunities in the small cap space right now. Don't miss out. This is the time to get rich.

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Nov 13, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS